Global Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Forecast 2024-2030- Product Image

Sale

Global Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Forecast 2024-2030

Report
195 Pages
March 2024
Region: Global
360iResearch™
ID: 5613065

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Therapeutic Vaccines Market size was estimated at USD 30.08 billion in 2023, USD 33.05 billion in 2024, and is expected to grow at a CAGR of 10.35% to reach USD 59.95 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Therapeutic Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Therapeutic Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic Vaccines Market, highlighting leading vendors and their innovative profiles. These include AFFiRiS AG, Agenus Inc., Argos Therapeutics Inc., Astellas Pharma, Inc., AstraZeneca PLC, Bavarian Nordic A/S, Celldex Therapeutics, Inc., CSL Limited, Emergent Biosolutions, Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer, Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd.

Market Segmentation & Coverage

This research report categorizes the Therapeutic Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

Vaccines Type
- Auto-Immune Diseases Vaccines
- Chronic Disease Vaccines
- Infectious Diseases Vaccines
- Neurological Disease Vaccines
Disease Indication
- Dengue
- DTP
- Hepatitis
- Human Papilloma Virus
- Influenza
- Meningococcal Disease
- MMR
- Pneumococcal Disease
- Polio
- Varicella
Administration
- Intramuscular & Subcutaneous Administration
- Oral Administration
End-User
- Adults
- Pediatrics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Therapeutic Vaccines Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Therapeutic Vaccines Market?
What are the technology trends and regulatory frameworks in the Therapeutic Vaccines Market?
What is the market share of the leading vendors in the Therapeutic Vaccines Market?
Which modes and strategic moves are suitable for entering the Therapeutic Vaccines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Therapeutic Vaccines Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence rate of diseases such as chronic and infectious diseases
5.1.1.2. Rising demand for biologics and drugs for targeted diseases
5.1.1.3. Growing government funding for vaccine development
5.1.2. Restraints
5.1.2.1. Side effects associated with therapeutic vaccines
5.1.2.2. Stringent government regulations for the approval of vaccines
5.1.3. Opportunities
5.1.3.1. Growing initiatives from government and private organizations to advance vaccination
5.1.3.2. Introduction of novel vaccines such as peptide-based therapeutic vaccines, and pneumococcal vaccines
5.1.3.3. Rising R&D activities and vaccines developments in the pipeline
5.1.4. Challenges
5.1.4.1. Slow processing of clinical trials for the production of some vaccine
5.1.4.2. High cost associated with the development of the therapeutic vaccines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Therapeutic Vaccines Market, by Vaccines Type

6.1. Introduction
6.2. Auto-Immune Diseases Vaccines
6.3. Chronic Disease Vaccines
6.4. Infectious Diseases Vaccines
6.5. Neurological Disease Vaccines

7. Therapeutic Vaccines Market, by Disease Indication

7.1. Introduction
7.2. Dengue
7.3. DTP
7.4. Hepatitis
7.5. Human Papilloma Virus
7.6. Influenza
7.7. Meningococcal Disease
7.8. MMR
7.9. Pneumococcal Disease
7.10. Polio
7.11. Varicella

8. Therapeutic Vaccines Market, by Administration

8.1. Introduction
8.2. Intramuscular & Subcutaneous Administration
8.3. Oral Administration

9. Therapeutic Vaccines Market, by End-User

9.1. Introduction
9.2. Adults
9.3. Pediatrics

10. Americas Therapeutic Vaccines Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Therapeutic Vaccines Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Therapeutic Vaccines Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. AFFiRiS AG
14.1.2. Agenus Inc.
14.1.3. Argos Therapeutics Inc.
14.1.4. Astellas Pharma, Inc.
14.1.5. AstraZeneca PLC
14.1.6. Bavarian Nordic A/S
14.1.7. Celldex Therapeutics, Inc.
14.1.8. CSL Limited
14.1.9. Emergent Biosolutions, Inc.
14.1.10. GlaxoSmithKline PLC
14.1.11. Johnson & Johnson Services, Inc.
14.1.12. Merck & Co., Inc.
14.1.13. Pfizer, Inc.
14.1.14. Sanofi S.A.
14.1.15. Serum Institute of India Pvt. Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. THERAPEUTIC VACCINES MARKET RESEARCH PROCESS
FIGURE 2. THERAPEUTIC VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. THERAPEUTIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. THERAPEUTIC VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. THERAPEUTIC VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THERAPEUTIC VACCINES MARKET DYNAMICS
FIGURE 7. THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2023 VS 2030 (%)
FIGURE 8. THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 10. THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THERAPEUTIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES THERAPEUTIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. THERAPEUTIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. THERAPEUTIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. THERAPEUTIC VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. THERAPEUTIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 6. THERAPEUTIC VACCINES MARKET SIZE, BY AUTO-IMMUNE DISEASES VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. THERAPEUTIC VACCINES MARKET SIZE, BY CHRONIC DISEASE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. THERAPEUTIC VACCINES MARKET SIZE, BY INFECTIOUS DISEASES VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. THERAPEUTIC VACCINES MARKET SIZE, BY NEUROLOGICAL DISEASE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 11. THERAPEUTIC VACCINES MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. THERAPEUTIC VACCINES MARKET SIZE, BY DTP, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. THERAPEUTIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. THERAPEUTIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMA VIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. THERAPEUTIC VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. THERAPEUTIC VACCINES MARKET SIZE, BY MENINGOCOCCAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. THERAPEUTIC VACCINES MARKET SIZE, BY MMR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. THERAPEUTIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. THERAPEUTIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. THERAPEUTIC VACCINES MARKET SIZE, BY VARICELLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 22. THERAPEUTIC VACCINES MARKET SIZE, BY INTRAMUSCULAR & SUBCUTANEOUS ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. THERAPEUTIC VACCINES MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. THERAPEUTIC VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. THERAPEUTIC VACCINES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. CANADA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. MEXICO THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES THERAPEUTIC VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. CHINA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. CHINA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. INDIA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. INDIA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. JAPAN THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. JAPAN THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. THAILAND THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. THAILAND THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 113. DENMARK THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. DENMARK THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. EGYPT THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. EGYPT THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. FINLAND THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. FINLAND THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. FRANCE THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. GERMANY THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. ITALY THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. NORWAY THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. NORWAY THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. POLAND THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. POLAND THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. QATAR THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. QATAR THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SPAIN THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. TURKEY THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. TURKEY THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM THERAPEUTIC VACCINES MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM THERAPEUTIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM THERAPEUTIC VACCINES MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM THERAPEUTIC VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. THERAPEUTIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 196. THERAPEUTIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 197. THERAPEUTIC VACCINES MARKET LICENSE & PRICING

Companies Mentioned

AFFiRiS AG
Agenus Inc.
Argos Therapeutics Inc.
Astellas Pharma, Inc.
AstraZeneca PLC
Bavarian Nordic A/S
Celldex Therapeutics, Inc.
CSL Limited
Emergent Biosolutions, Inc.
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Pfizer, Inc.
Sanofi S.A.
Serum Institute of India Pvt. Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 33.05 Billion
Forecasted Market Value ( USD ) by 2030	$ 59.95 Billion
Compound Annual Growth Rate	10.3%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global mRNA Platform Market by Indication (Autoimmune Diseases, Cancer, Infectious Diseases), Usability (Prophylactic Vaccines, Therapeutic Drugs, Therapeutic Vaccines), mRNA Type, End-User - Forecast 2024-2030

Global Vaccine Vial Monitor Market by Type (Multi-Dose, Single Dose), Application (Preventive Vaccine, Therapeutic Vaccine) - Forecast 2024-2030

Therapeutic Vaccines - Global Strategic Business Report

Therapeutic Vaccines Market Report by Type, Disease Type, Technology, Distribution Channel, and Region 2024-2032

Vaccine Vials Market by Report Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity (10ml, 20ml, 2ml, 3ml, 5ml), Application (Preventive Vaccine, Therapeutic Vaccine), and Region 2024-2032

About the Therapeutic Vaccine Market